ASND logo

Ascendis Pharma A/S (ASND)

Profile

Full Name

Ascendis Pharma A/S

Ticker

NASDAQ: ASND

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Denmark

IPO

January 28, 2015

Indexes

Not included

Website

https://ascendispharma.com

Employees

1017

Key Details

Price

$201.94(0.47%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$393.35M(36.41% YoY)

Annual EPS

-$7.06(23.60% YoY)

PE Ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $201.94
    ASND price is $201.94

    30-Day Relative Volume

    1.26
    ASND 30-day relative volume is 1.26

    Price Performance

    Price 1-Day Change

    +0.47%
    ASND price is up +0.47% today

    Price YTD Change

    +46.69%
    ASND price is up +46.69% since January 1st

    Price 1-Year Change

    +55.57%
    ASND price is up +55.57% year-on-year

    Price 3-Year Change

    +88.98%
    ASND price is up +88.98% over the past 3 years

    Price Range

    Price All-Time High

    $216.45
    ASND price is currently -6.70% below its historical high of $216.45

    Price 3-Year Low

    $64.33
    ASND price is currently +213.92% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $12.23B
    ASND market cap is $12.23 billion

    Market Cap 3-Year Change

    +100.67%
    ASND market cap is up +100.67% over the past 3 years

    Market Cap All-Time High

    $13.01B
    ASND market cap is currently -5.97% below its historical high of $13.01 billion

    Market Cap Sector Percentile

    92.99%
    ASND market cap is higher than 92.99% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.33%
    ASND shares outstanding is up +1.33% year-on-year

    Shares Outstanding 3-Year Change

    +6.19%
    ASND shares outstanding is up +6.19% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.46
    ASND beta is 0.46

    200-day SMA

    $168.52
    ASND price is currently +19.84% above its 200-day simple moving average

    50-day SMA

    $199.80
    ASND price is currently +1.07% above its 50-day simple moving average

    14-Day RSI

    47.27
    ASND 14-day relative strength index is 47.27

    Volume

    1.26
    ASND 30-day relative volume is 1.26

    ATR

    $7.38
    ASND average true range is $7.38

    10-day Historical Volatility

    22.79%
    ASND 10-day historical volatility is 22.79%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $393.35M
    ASND annual revenue is $393.35 million

    Revenue Analysts Estimate

    $725.34M
    ASND annual revenue is currently -45.77% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +36.41%
    ASND annual revenue is up +36.41% year-on-year

    Revenue Sector Percentile

    79.38%
    ASND annual revenue is higher than 79.38% of companies in Healthcare sector

    EPS

    EPS

    -$7.06
    ASND annual earnings per share is -$7.06

    EPS Analysts Estimate

    -$2.51
    ASND annual earnings per share is currently -181.15% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +23.6%
    ASND annual earnings per share is up +23.6% year-on-year

    EPS Sector Percentile

    16.99%
    ASND annual earnings per share is higher than 16.99% of companies in Healthcare sector

    Profit

    Gross Profit

    $333.14M
    ASND annual gross profit is $333.14 million

    Gross Margin

    84.69%
    ASND annual gross profit margin is 84.69%

    Operating Profit

    -$301.54M
    ASND annual operating income is -$301.54 million

    Operating Margin

    -76.66%
    ASND annual operating profit margin is -76.66%

    Net Income

    -$408.97M
    ASND annual net profit is -$408.97 million

    Net Margin

    -103.97%
    ASND annual net profit margin is -103.97%

    Expenses

    Total Expenses

    $802.32M
    ASND annual total expenses is $802.32 million

    Operating Expenses

    $634.68M
    ASND annual total operating expenses is $634.68 million

    Cost Of Goods Sold

    $60.20M
    ASND annual cost of goods sold is $60.20 million

    Selling, General & Administrative Expenses

    $314.93M
    ASND annual SG&A is $314.93 million

    Depreciation & Amortization

    $19.16M
    ASND annual D&A is $19.16 million

    Interest Expense

    $0.00
    ASND annual interest expense is $0.00

    Income Tax

    $5.24M
    ASND annual income tax is $5.24 million

    EBIT & EBITDA

    EBIT

    -$301.54M
    ASND annual earnings before interest & taxes is -$301.54 million

    EBITDA

    -$282.37M
    ASND annual EBITDA is -$282.37 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $1.22B
    ASND annual total assets is $1.22 billion

    Non Current Assets

    $123.45M
    ASND annual long term assets is $123.45 million

    Current Assets

    $1.10B
    ASND annual total current assets is $1.10 billion

    Cash and Cash Equivalents

    $582.24M
    ASND annual cash & cash equivalents is $582.24 million

    Accounts Receivable

    $173.03M
    ASND annual accounts receivable is $173.03 million

    Inventory

    $306.10M
    ASND annual inventory is $306.10 million

    Liabilities

    Total Liabilities

    $1.33B
    ASND annual total liabilities is $1.33 billion

    Long Term Liabilities

    $392.65M
    ASND annual total long term liabilities is $392.65 million

    Current Liabilities

    $944.70M
    ASND annual current liabilities is $944.70 million

    Accounts Payable

    $100.30M
    ASND annual accounts payable is $100.30 million

    Debt

    Total Debt

    $887.03M
    ASND annual total debt is $887.03 million

    Total Debt 1-Year Change

    +24.64%
    ASND annual total debt is up +24.64% year-on-year

    Long Term Debt

    $378.04M
    ASND annual long term debt is $378.04 million

    Short Term Debt

    $508.99M
    ASND annual short term debt is $508.99 million

    Equity & Capital

    Shareholders Equity

    -$109.46M
    ASND annual stockholders equity is -$109.46 million

    Book Value

    -$109.99M
    ASND annual book value is -$109.99 million

    Retained Earnings

    -$2.65B
    ASND annual retained earnings is -$2.65 billion

    Working Capital

    $158.43M
    ASND annual working capital is $158.43 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$331.21M
    ASND annual cash from operations is -$331.21 million

    Cash From Operations 1-Year Change

    +34.45%
    ASND annual cash from operations is up +34.45% year-on-year

    Cash From Investing

    $7.44M
    ASND annual cash from investing is $7.44 million

    Cash From Investing 1-Year Change

    -97.6%
    ASND annual cash from investing is down -97.6% year-on-year

    Cash From Financing

    $480.19M
    ASND annual cash from financing is $480.19 million

    Cash From Financing 1-Year Change

    +230.75%
    ASND annual cash from financing is up +230.75% year-on-year

    CAPEX

    CAPEX

    $1.54M
    ASND annual capital expenditures is $1.54 million

    CAPEX 1-Year Change

    -41.53%
    ASND annual capital expenditures is down -41.53% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$332.75M
    ASND annual free cash flow is -$332.75 million

    Free Cash Flow 1-Year Change

    +34.49%
    ASND annual free cash flow is up +34.49% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    84.69%
    ASND annual gross profit margin is 84.69%

    Operating Margin

    -76.66%
    ASND annual operating profit margin is -76.66%

    Net Margin

    -103.97%
    ASND annual net profit margin is -103.97%

    ROA & ROE

    ROA

    -38.34%
    ASND annual return on assets is -38.34%

    ROE

    373.63%
    ASND annual return on equity is 373.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ASND price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ASND price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -55.54
    ASND price to book ratio is -55.54

    PB Ratio Sector Percentile

    1.62%
    ASND price to book ratio is higher than 1.62% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    22.88
    ASND price to sales ratio is 22.88

    PS Ratio Sector Percentile

    80.72%
    ASND price to sales ratio is higher than 80.72% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $12.58B
    ASND enterprise value is $12.58 billion

    Enterprise Value Sector Percentile

    92.89%
    ASND enterprise value is higher than 92.89% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -49.07
    ASND EV/EBITDA is -49.07

    EV/EBITDA Sector Percentile

    3.26%
    ASND EV/EBITDA is higher than 3.26% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.17
    ASND annual current ratio is 1.17

    Quick Ratio

    0.84
    ASND annual quick ratio is 0.84

    Leverage

    Debt To Equity

    -8.10
    ASND annual debt to equity ratio is -8.10

    Interest Coverage Ratio

    -
    ASND annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    ASND piotroski f-score is 4

    Altman Z-Score

    2.14
    ASND altman z-score is 2.14

    Analyst ratings

    Recent major analysts updates

    Oct 17, 25 Raymond James
    Strong Buy
    Oct 13, 25 Cantor Fitzgerald
    Overweight
    Oct 9, 25 JP Morgan
    Overweight
    Sep 2, 25 B of A Securities
    Buy
    Aug 19, 25 JP Morgan
    Overweight
    Aug 8, 25 Wells Fargo
    Overweight
    Aug 8, 25 Wedbush
    Outperform
    Aug 8, 25 UBS
    Buy
    Aug 8, 25 Stifel
    Buy
    Aug 8, 25 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with ASND included

    Growing Shares Outstanding
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    Oversold stocks with upcoming earnings
    • What is the ticker symbol for Ascendis Pharma A/S?
    • Does Ascendis Pharma A/S pay dividends?
    • What sector is Ascendis Pharma A/S in?
    • What industry is Ascendis Pharma A/S in?
    • What country is Ascendis Pharma A/S based in?
    • When did Ascendis Pharma A/S go public?
    • Is Ascendis Pharma A/S in the S&P 500?
    • Is Ascendis Pharma A/S in the NASDAQ 100?
    • Is Ascendis Pharma A/S in the Dow Jones?
    • When was Ascendis Pharma A/S's last earnings report?
    • When does Ascendis Pharma A/S report earnings?

    What is the ticker symbol for Ascendis Pharma A/S?

    The ticker symbol for Ascendis Pharma A/S is NASDAQ:ASND

    Does Ascendis Pharma A/S pay dividends?

    No, Ascendis Pharma A/S does not pay dividends

    What sector is Ascendis Pharma A/S in?

    Ascendis Pharma A/S is in the Healthcare sector

    What industry is Ascendis Pharma A/S in?

    Ascendis Pharma A/S is in the Biotechnology industry

    What country is Ascendis Pharma A/S based in?

    Ascendis Pharma A/S is headquartered in Denmark

    When did Ascendis Pharma A/S go public?

    Ascendis Pharma A/S's initial public offering (IPO) was on January 28, 2015

    Is Ascendis Pharma A/S in the S&P 500?

    No, Ascendis Pharma A/S is not included in the S&P 500 index

    Is Ascendis Pharma A/S in the NASDAQ 100?

    No, Ascendis Pharma A/S is not included in the NASDAQ 100 index

    Is Ascendis Pharma A/S in the Dow Jones?

    No, Ascendis Pharma A/S is not included in the Dow Jones index

    When was Ascendis Pharma A/S's last earnings report?

    Ascendis Pharma A/S's most recent earnings report was on August 7, 2025

    When does Ascendis Pharma A/S report earnings?

    The next expected earnings date for Ascendis Pharma A/S is November 6, 2025
    On this page